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A B S T R A C T
Background
Follicular structures resembling germinal centres (GCs) that are characterized by follicular
dendritic cell (FDC) networks have long been recognized in chronically inflamed tissues in
autoimmune diseases, including the synovium of rheumatoid arthritis (RA). However, it is
debated whether these ectopic structures promote autoimmunity and chronic inflammation
driving the production of pathogenic autoantibodies. Anti-citrullinated protein/peptide
antibodies (ACPA) are highly specific markers of RA, predict a poor prognosis, and have been
suggested to be pathogenic. Therefore, the main study objectives were to determine whether
ectopic lymphoid structures in RA synovium: (i) express activation-induced cytidine deaminase
(AID), the enzyme required for somatic hypermutation and class-switch recombination (CSR) of
Ig genes; (ii) support ongoing CSR and ACPA production; and (iii) remain functional in a RA/
severe combined immunodeficiency (SCID) chimera model devoid of new immune cell influx
into the synovium.
Methods and Findings
Using immunohistochemistry (IHC) and quantitative Taqman real-time PCR (QT-PCR) in
synovial tissue from 55 patients with RA, we demonstrated that FDCþ structures invariably
expressed AID with a distribution resembling secondary lymphoid organs. Further, AIDþ/CD21þ
follicular structures were surrounded by ACPAþ/CD138þ plasma cells, as demonstrated by
immune reactivity to citrullinated fibrinogen. Moreover, we identified a novel subset of synovial
AIDþ/CD20þ B cells outside GCs resembling interfollicular large B cells. In order to gain direct
functional evidence that AIDþ structures support CSR and in situ manufacturing of class-
switched ACPA, 34 SCID mice were transplanted with RA synovium and humanely killed at 4 wk
for harvesting of transplants and sera. Persistent expression of AID and Ic-Cl circular transcripts
(identifying ongoing IgM-IgG class-switching) was observed in synovial grafts expressing FDCs/
CD21L. Furthermore, synovial mRNA levels of AID were closely associated with circulating
human IgG ACPA in mouse sera. Finally, the survival and proliferation of functional B cell niches
was associated with persistent overexpression of genes regulating ectopic lymphoneogenesis.
Conclusions
Our demonstration that FDCþ follicular units invariably express AID and are surrounded by
ACPA-producing plasma cells provides strong evidence that ectopic lymphoid structures in the
RA synovium are functional and support autoantibody production. This concept is further
confirmed by evidence of sustained AID expression, B cell proliferation, ongoing CSR, and
production of human IgG ACPA from GCþ synovial tissue transplanted into SCID mice,
independently of new B cell influx from the systemic circulation. These data identify AID as a
potential therapeutic target in RA and suggest that survival of functional synovial B cell niches
may profoundly influence chronic inflammation, autoimmunity, and response to B cell–
depleting therapies.
The Editors’ Summary of this article follows the references.
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Introduction
Rheumatoid arthritis (RA) is a chronic inﬂammatory
erosive polyarthritis with an associated signiﬁcant morbidity
and mortality [1]. One of the hallmarks of the disease is the
presence of circulating autoantibodies, such as rheumatoid
factor (RF) [2] and anti-citrullinated protein/peptide anti-
bodies (ACPA) [3–8], that have prompted the notion of an
autoimmune pathogenesis. The presence of such antibodies,
particularly ACPA, has been shown to be a poor prognostic
factor linked with a higher erosive burden [9,10], while ACPA
titres have been reported to fall in line with clinical response
to biological therapies [11]. Additional support for a
pathogenic role of ACPA antibodies comes from recent work
in a mouse model of RA that indicated a direct role for ACPA
antibodies in tissue destruction [12].
Physiologically, antigen-driven antibody responses take
place within germinal centres (GCs) of secondary lymphoid
organs where the processes of somatic hypermutation (SHM)
and class switch recombination (CSR) of the Ig genes in GC-B
cells occur, leading to afﬁnity maturation and differentiation
to memory B and plasma cells [13,14]. However, recent
evidence suggests that CSR and low-level SHM can also be
sustained at extrafollicular sites in the spleen [15] and the gut
[16]. Both CSR and SHM are initiated by and critically
dependent upon the expression of the enzyme activation-
induced cytidine deaminase (AID) [17]. Although the exact
mechanism of action of AID is currently unclear [18], CSR
occurs via excision of switch circles following the introduc-
tion of double strand breaks in the Ig switch regions of DNA,
with the subsequent substitution of IgM and IgD with IgG,
IgE, or IgA [19], and hence production of antibodies with
speciﬁc effector functions. AID also initiates SHM by
introducing point mutations in the variable genes encoding
the antigen-binding region of Igs [20], and afﬁnity maturation
then occurs through cycles of antigen-dependent selection in
GC. Accordingly, AID expression in secondary lymphoid
organs has been demonstrated to be restricted to GC-B cells
actively undergoing CSR/SHM and to the recently described
population of interfollicular (IF) large B cells [21–23].
Therefore, delineation of its expression within tissue allows
identiﬁcation of whether and where B cells activate the
molecular machinery responsible for the production of
afﬁnity-matured antibodies.
The presence of ectopic lymphoid structures resembling
GCs and characterized by follicular dendritic cell (FDC)
networks is a common ﬁnding in chronically inﬂamed tissues
in several autoimmune diseases [24] including RA. GC-like
structures have been reported to occur in the synovial
membrane in approximately 25% of patients with RA [25].
We and others have shown that alongside the frequent
recognition of disorganized cell clusters in the synovium,
some of the sublining lymphoid aggregates can recapitulate
qualitative features of secondary lymphoid organs, such as
FDC networks, the in situ production of homeostatic
chemokines, as well as the acquisition of variable degrees of
T/B cell segregation or high endothelial venule development
[26–29]. However, whether ectopic lymphoid structures in RA
can be functional and directly implicated in promoting the
production of disease-speciﬁc and potentially pathogenic
autoantibodies such as ACPA, or whether the synovium acts
as a ‘‘reservoir’’ for long-lived plasma cells producing ACPA is
at present unclear [30]. Circumstantial evidence, such as the
presence of clonally mutated B cells from GC-like structures
microdissected from RA tissues [31,32], suggests that an
antigen-driven B cell response is taking place in the RA
synovium. Likewise, the detection of ACPA in the synovial
ﬂuid of patients with RA [33,34], the demonstration that
ACPA are concentrated at this site [35], and the detection of
ACPA in the sera of SCID mice xenotransplanted with human
synovium [36], support the possibility that ACPA might be
directly generated in the synovium. These data, however,
cannot rule out the possibility that already mutated,
autoreactive B cells are preferentially recruited to the
inﬂamed synovial tissue. In addition, lymphoid aggregates
can also occur in the synovium of patients with other
rheumatological conditions currently not associated with
autoantibodies of known speciﬁcity[30], and further no
correlation has been found between their presence and
serum/synovial ﬂuid ACPA [30,37]. These concepts have been
taken as an indication that these structures may not be
functional and that B cell autoimmunity in RA synovitis may
be independent of ectopic lymphoneogenesis [30,37,38].
Thus, the purpose of this study was to investigate whether
ectopic lymphoid structures in RA synovium are functional
by determining whether they: (i) express AID, the enzyme
required for SHM and CSR of Ig genes; (ii) support ongoing
CSR and the production of high-afﬁnity ACPA; and (iii)
remain functional and promote B cell survival, proliferation,
and autoantibody production in an RA/SCID chimera model
devoid of any new immune cell inﬂux into the synovium and
where the ongoing immunological activity of secondary
lymphoid organs is excluded.
Materials and Methods
Patients and Samples
Following written informed consent, synovial tissue was
collected from 55 patients with RA fulﬁlling the revised 1987
ACR criteria for RA [39]. Tissues were collected consecutively
within each group studied, which included arthroplastic joint
surgery (40) and ultrasound-guided synovial biopsy (15). The
majority of the patients were on methotrexate, and none
were on anti-TNF therapy at the time of surgery. Demo-
graphic data are given for the study population in Table 1.
From 24 of the 55 patients who underwent joint replace-
ment surgery between 1999 and 2005, only formaldehyde ﬁxed,
parafﬁn-embedded tissue was available and therefore was
exclusively used for histological analysis. From an additional 25
patients (of whom ten underwent arthroplastic surgery and 15
underwent ultrasound-guided biopsy), enrolled between 2005
and 2008, paired parafﬁn and RNA samples were available and
were used for histological analysis and QT-PCR. Finally, from
six patients with RA undergoing joint replacement surgery,
synovial tissue was obtained and stored in liquid nitrogen until
use for transplantation into SCID mice.
Procedures were approved by the hospital Ethics Commit-
tee (REC/98/11/27 Guys and St. Thomas’ NHS Trust and REC
05/Q0703/198 Barts and the London NHS Trust) and
performed after written informed consent.
Immunohistochemistry
A list of primary and secondary antibodies (Abs) used is
reported in Table 2.
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Histological Grading of Tissues
The histological grading of tissues and degree of lymphoid
organization was assessed by immunohistochemical staining
of sequentially cut sections of RA synovial tissue, as
previously reported [27]. Brieﬂy, parafﬁn-embedded 5 lm
sections underwent routine staining with haematoxylin and
eosin in order to deﬁne the predominant histological pattern
of RA synovitis as either diffuse or aggregate [25]. The
number of lymphocytic aggregates was counted in each
section and graded according to a modiﬁed, previously
published grading system [27,40] with grade 1 (G1) aggregates
displaying a radial cell number between 2 and 5 cells, grade 2
(G2) between 6 and 10 cells and grade 3 (G3) greater than 10
cells.
Staining for CD3 and CD20 (using antibody dilutions of
1:50 and 1:20 respectively), following antigen retrieval with
Target retrieving solution (DAKO), was used to analyse T/B
cell segregation as previously reported [41]. In addition,
following proteinase K digestion (DAKO), single staining with
CD21 at a dilution of 1:20 was performed to identify FDC
networks characterising GC-like structures [41].
Based on the results of the CD21 staining and the presence
of G2/G3 aggregates, samples were qualitatively classiﬁed as
either diffuse, aggregate/CD21, or aggregate/CD21þ as
previously described [26]. In order to minimize bias due to
cutting level, all blocks of tissue were cut and stained at three
cutting levels 50 lm apart.
Relationship between Histological Grade of Tissue,
Degree of Inflammatory Infiltrate Organization, and AID
Expression within Tissues
Staining for AID was performed, as previously reported
[42], on sequential sections of the RA synovial tissue in order
to correlate AID expression with the histological grading and
degree of lymphoid organization. Brieﬂy, after antigen
unmasking using Target retrieval solution (pH 6, DAKO)
and incubation with 20% rabbit serum (DAKO), incubation
with the EK2-5G9 primary Ab was carried out at a dilution of
1:20 for 1 h at room temperature. This step, in turn, was
followed by a 1 h incubation with the biotinylated rabbit anti-
rat Ig secondary Ab. The HRP–streptavidin-biotin complex
(DAKO) was then added to the section and incubated for 30
min. The colour reaction was developed with diaminobenzi-
dine (DAKO).
Table 1. Clinical and Histological Characteristics of RA Patients (n ¼ 55)
Group Characteristic
Clinical characteristics Age (y) mean 6 SD 53 612.2 y
Female (%) 76.3%
Disease duration (y) mean 6 SD 13.2 6 17.1 y
Rheumatoid factorþ (%) 80%
Pathological scores of synovial tissues Aggregate (CD21 networkþ) tissue (%) 29%
Aggregate (CD21 network–) tissue (%) 31%
Diffuse tissues (%) 40%
Patients with paired synovial tissue and serum n ¼ 21 ACPAþ (%) 71%
Serum; ACPAþ, tissue; AID/CD21Lþ (%) 75%
Serum; ACPAþ, tissue; AID/CD21L (%) 67%
doi:10.1371/journal.pmed.0060001.t001
Table 2. Primary and Secondary Antibodies Used for Immunohistochemistry
Antibody Category Clone/Type Specificity Host Source
Primary L-26 Human CD20 Mouse DAKO
A2452 Human CD3 Rabbit DAKO
IF8 Human CD21 Mouse DAKO
124 Human Bcl-2 Mouse DAKO
IgD Human IgD Rabbit DAKO
PG-B6p Human Bcl-6 Mouse DAKO
EK2-5G9 Human AID Rat [23]
M7187 Human Ki67 Mouse DAKO
MI15 Human CD138 Mouse DAKO
Secondary Rabbit anti-rat biotin Rat Ig Rabbit (biotinylated) DAKO
Goat anti-mouse Mouse Ig Goat (biotinylated) DAKO
Rabbit anti-mouse biotinylated Mouse Ig Rabbit (biotinylated) DAKO
Goat anti-mouse ALEXA 488 Mouse IgG1 Goat Invitrogen
Goat anti-mouse ALEXA-594 Mouse IgG2a Goat Invitrogen
ABC-HRP/AP DAKO
Streptavidin Alexa 555 Biotin Invitrogen
Envision AP/HRP DAKO
doi:10.1371/journal.pmed.0060001.t002
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Relationship between AID and CD21L Expression, as
Determined by QT-PCR and Histological Characterization
of Synovial Tissues
Synovial samples were obtained from an additional 25
patients with RA (the same extra 25 mentioned above). Each
specimen was divided into 2 parts; one was formalin ﬁxed and
parafﬁn embedded for immunohistology and the second was
stored in a 10:1 v:v of RNA-later (Ambion) at80 8C for RNA
extraction and QT-PCR analysis. Histological characteriza-
tion of the RA tissue was carried out as described above. Total
RNA was extracted from the remaining portion of synovial
tissue, using the RNeasy Mini Kit (Qiagen), with on column
DNase I digestion to avoid genomic DNA contamination.
cDNA was generated from 1 lg of RNA using the Thermo-
script RT-PCR System for First-Strand cDNA Synthesis
(Invitrogen). QT-PCR was performed to detect mRNA
expression levels of AID and CD21L together with CXCL13,
LTb, BAFF and APRIL using speciﬁc primers and probes (see
Table 3). The RT-PCR was run in triplicate with an equal
loading of 20 ng of cDNA/well. Results were analysed after 40
cycles of ampliﬁcation using the ABI PRISM 7900HT
Sequence Detection System Version 2.1. Relative quantiﬁca-
tion was measured using the Comparative CT (Threshold
Cycle) Method. cDNA from peripheral blood mononuclear
cells sorted for CD3 by ﬂuorescence activated cell sorting
(FACS) were used as a negative control for AID and CD21L,
whereas cDNA from lymph node was used as a positive
control.
Detection and Characterization of ACPA-Producing Cells
within Rheumatoid Synovial Tissue
Citrullinated Fb (CFb) was generated as previously
described with minor modiﬁcations [43,44]. Brieﬂy, plasmi-
nogen-depleted human Fb (Calbiochem: EMD BioSciences)
was incubated at 0.86 mg/ml with 10 U/ml of rabbit skeletal
muscle peptidyl arginine deiminase (Sigma-Aldrich) in 0.1 M
Tris-HCl (pH 7.4), 10 mM CaCl2, and 5 mM DTT for 2 h at 50
8C. The enzyme was inactivated by adding 2% SDS and
heating at 100 8C for 3 min and removed by serial spinning
and washing with 0.01 M sterile bicarbonate buffer in a 100
kDa Amicon ﬁlter device (Millipore). CFb was then biotiny-
lated using NHS-LC biotin (Pierce Biotechnology). In
addition, an aliquot of unmodiﬁed Fb of the same concen-
tration as the CFb was biotinylated and used as a negative
control for all staining experiments.
To conﬁrm effective citrullination and the speciﬁcity of
CFb for ACPA Abs, two aliquots of CFb and uncitrullinated
Fb were ﬁrst separated by SDS-PAGE on 7.5% polyacrylamide
gels. Proteins were then electrotransferred onto Hybond-C
extra reinforced nitrocellulose membranes (Amersham).
Membrane strips were probed with human sera (1:100)
pooled from three ACPAþpatients with RA and three ACPA–
patients with RA. A goat anti-human IgG peroxidase (Sigma)
was used for detection of the primary Ab. Peroxidase activity
was visualized using ECL Western blotting reagents (Amer-
sham) following the manufacturer’s instructions.
To detect and characterise ACPA-producing cells in the RA
synovium, sequentially cut 5lm parafﬁn and/or frozen
sections of ﬁve RA synovial samples representative of differ-
ent degrees of histological organization (three aggregate/
CD21þ, one aggregate/CD21, one diffuse) were chosen for
analysis. ACPA-producing cells and B cell follicles were
identiﬁed using double immunoﬂuorescence with biotiny-
lated CFb followed by incubation with streptavidin ALEXA-
555 and CD20 followed by rabbit anti-mouse ALEXA-488
with subsequent DAPI counterstaining [43]. AIDþ FDC
networks were identiﬁed on sequential sections by staining
for CD21 using conventional IHC as described above and
immunoﬂuorescent staining for AID using streptavidin-
ALEXA-555 following incubation with biotinylated rabbit
anti-rat secondary Ab. Plasma cells producing ACPA were
identiﬁed by performing double immunoﬂuorescence for
CD138 followed by goat anti-mouse ALEXA-488 and bio-
tinylated CFb as described above. All sections were visualised
using an Olympus BX60 microscope and epiﬂuorescence.
Tissue Transplantation
A total of 56 samples of human synovium from six patients
with RA undergoing arthroplasty (classiﬁed prior to trans-
plantation histologically as two diffuse, two aggregate/CD21,
and two aggregate/CD21þ) were transplanted subcutaneously
into Beige SCID-17 mice as previously described [45,46]. Each
mouse was double transplanted with tissue obtained from
adjacent pieces of synovium from the same patient, thus
minimizing variability of transplants within each mouse.
Thirty-four mice were double transplanted. From the total of
68 transplants, 12 could not be used for the analysis due to
either resorption of the transplant or poor RNA yield. (Such a
rate of graft loss is not uncommon in our experience, thus in
order to keep animal numbers to a minimal level, double
transplantation is normal practice in our laboratory.) In this
model, full engraftment of human tissue is reached at 7 d, and
signiﬁcant levels of ACPA antibodies in mouse sera have been
described from a similar time point and up to 84 d [36]. Four
weeks post-transplantation we determined: (i) the histomor-
phology of the transplanted synovium with regard to the
presence of CD21þ aggregates; (ii) the mRNA expression
levels of AID, CD21L, and genes involved in ectopic
lymphoneogenesis; (iii) the presence of ongoing CSR by
assaying for the presence of Ic-Cl circular transcripts
(molecular by products of IgM to IgG class switching); and
(iv) the serum levels of human ACPA in the mouse
circulation.
Animals were humanely killed at 4 wk and the grafts
divided into two parts; one part was parafﬁn embedded for
later histological examination and one part was stored in 10:1
v:v of RNA-later (Ambion) at80 8C for QT-PCR. Grafts were
examined macroscopically and histologically to conﬁrm
Table 3. Genes, Specific Primers, and Probes used for QT-PCR
Gene RefSeq Gene Expression Assay ID
AID NM_020661 Hs00221068_m1
CD21L NM_001006658 Hs01079084_g1
BAFF NM_006573 Hs00198106_m1
APRIL NM_003808 Hs00182565_m1
LTb NM_002341 Hs 00242737_m1
CXCL13 NM_006419 Hs00757930_m1
TNFa NM_00594.2 Hs00174128_m1
Human b actin NM_001101 Hs99999903_m1
Source of all primers and probes: Applied Biosystems.
doi:10.1371/journal.pmed.0060001.t003
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viability. In addition, transplanted synovial tissues were
characterised by staining for CD21 and AID to identify
persisting AIDþ FDC networks. Proliferating B cells were
identiﬁed by performing double immunoﬂuorescence for
Ki67 followed by goat anti-mouse IgG1 ALEXA-488 and CD20
followed by goat anti-mouse IgG2a ALEXA-594.
Finally, mice underwent a terminal bleed, and serum was
collected and stored at20 8C for subsequent ACPA analysis.
Gene Expression Analysis by QT-PCR and Detection of
Circular Transcripts in Transplanted RA Synovial Tissues
RNA was extracted from each transplant, and cDNA was
generated as described above. QT-PCR was performed to
measure mRNA expression levels of AID, CD21L, APRIL,
BAFF, TNFa, LTb, and CXCL13 (see Table 3).
Detection of Ic-Cl circular transcripts was performed on
the same cDNA. Circular transcripts were detected following
Figure 1. AID Expression within the Rheumatoid Synovial Membrane Is Restricted to Lymphoid Aggregates with FDC Networks
A representative example of sequential paraffin-embedded sections of LN and RA synovial membrane stained for AID (brown, A, E, I), T cells (CD3,
brown, B, F, J), B cells (CD20, red, C,G, K) and follicular DCs (CD21, red, D,H, L). The presence of FDC networks was invariably associated with the
expression of AID even in FDCþ grade 3 aggregates (arrow, A), without morphologically detectable dark and light zones within the B cell rich area
(AD). In more organised grade 3 aggregates (EH), expression was more prominent and closely resembled that seen in secondary lymphoid organs,
such as the LN (IL) (original magnification was 203). Scale bars 200 lm.
doi:10.1371/journal.pmed.0060001.g001
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30 cycles of RT-PCR ampliﬁcation using the reverse primer
Cl (59-GTTGCCGTTGGGGTGCTGGAC-39) together with
the forward primer Ic (59-GGGCTTCCAAGCCAACAGGG-
CAGGACA-39) recognizing both Ic1 and Ic2 (the RT-PCR
product was 557 bp) as previously reported [47]. Before each
RT-PCR, cDNA were denatured for 5 min at 94 8C. The PCR
conditions were as follows: denaturation for 1 min at 94 8C,
annealing for 1 min at 60 8C, and extension for 1 min at 72 8C.
Detection of Human IgG ACPA in Human and Mouse Sera
ACPA were detected in both mouse and human sera using a
commercially available anti-cyclic-citrullinated antibody
(anti-CCP2) ELISA kit (Axis Shield), following the manufac-
turer’s instructions. A positive result was taken as . 5 U/l.
Statistical Analysis
Differences in quantitative variables were analysed by the
Mann Whitney U test when comparing two groups, and by the
Kruskal-Wallis with Dunn’s post test when comparing multi-
ple groups. v2 test with Yates’ correction when required or
Fisher’s exact test when appropriate were used to evaluate
associations of qualitative variables in the different groups.
Spearman’s rank correlation was performed to correlate
expression levels of AID and CD21L mRNA in RA synovial
grafts. All the statistical analyses were performed using
GraphPad Prism version 3.03 for Windows (GraphPad
Software). A p-value of , 0.05 was considered statistically
signiﬁcant.
Results
In the Rheumatoid Synovial Membrane AID Is Expressed
Only in Association with FDCs
In order to investigate whether AID was expressed within
the rheumatoid synovial membrane and its potential associ-
ation with speciﬁc patterns of rheumatoid synovitis, we ﬁrst
performed an IHC analysis on sequential sections of synovial
tissue in 24 patients with RA. We analysed AID expression in
relation to the degree of lymphoid organization of the
inﬂammatory inﬁltrate, including T/B cell segregation and
FDC network formation.
As shown in a representative example in Figure 1, AID
expression in RA synovium was invariably associated with the
presence of FDCs (Figure 1A–1H). This was the case even in
CD21þ G3 aggregates that lacked uniform T/B cell segrega-
tion and distinct dark –light zones within the B cell rich area
[32] (Figure 1 A–1D). The pattern of AID staining within
compartmentalized CD21þG3 aggregates (Figure 1E–1H) was
highly reminiscent of the pattern seen in secondary
lymphoid organs, such as lymph node, with strong AID
expression within GC B cells (Figure 1I–1L). CD21þ FDC
networks were observed in seven out of 24 patients (29%),
with 100% of G3 aggregates displaying CD21þ FDC networks
also expressing AID. Conversely, AID and FDC networks were
not detectable either in smaller G1 or G2 aggregates or in
diffuse tissues.
QT-PCR Evaluation Confirms the Exclusive Association
between AID and FDCs
In order to conﬁrm whether AID expression was also
exclusively associated with FDC networks at the mRNA level,
we analysed synovial samples from an additional cohort of 25
patients with RA in which paired RA specimens for IHC and
QT-PCR were available. In this cohort, we investigated the
expression of CD21L, a marker exclusively expressed by FDCs
[48], and AID transcripts. Indeed, AID mRNA expression was
detected in all 12 of the CD21Lþ RA samples but in none of
the 13 CD21L RA samples analysed (Figure 2A, p , 0.0002).
Amplicons of the expected length (99 bp for AID and CD21L,
and 171bp for b-actin, Figure 2B) were seen in samples
positive for AID and CD21L by QT-PCR (lane 2) and human
lymph node (lane 5), but not in RA samples negative for AID
and CD21L (lane 3) or in the negative control (lane 4, cDNA
from CD3 sorted cells).
In the same cohort of 25 patients we compared the
expression of AID and CD21L mRNA by QT-PCR with
histological characterization of the same piece of synovial
tissue. We identiﬁed by IHC an aggregate pattern AIDþ/
CD21þ in seven patients (28%), aggregate pattern AID/
CD21 in seven (28%) patients, and diffuse inﬁltrate
negative for both AID and CD21 in 11 patients (44%). On
the other hand, when the same samples were analysed by
QT-PCR, we demonstrated a higher prevalence of RA
synovial tissues expressing AID and CD21L mRNA (12/25,
48%). Notably, the increased proportion of RA synovial
tissues expressing AID and CD21L mRNA was exclusively
characterised by an aggregate and not a diffuse pattern,
conﬁrming that lymphoid structures are required for the
expression of both AID and CD21L mRNA in the RA
synovial membrane.
Expression of AID Is Associated with the Up-regulation of
CXCL13 and LTb within the Rheumatoid Synovial
Membrane
As synovial tissues containing sites of ectopic lymphoneo-
genesis have been demonstrated to be closely associated with
increased expression levels of CXCL13 and LTb mRNA [26],
we then sought to determine whether the expression levels of
these and other key factors involved in lymphoneogenesis
were also signiﬁcantly associated with the up-regulation of
AID and CD21L mRNA. As shown in Figure 2, AID mRNAþ
tissues displayed signiﬁcantly higher levels of CXCL13 and
LTb mRNA (Figure 2C and 2D) but not of the B cell survival
factor BAFF (Figure 2F). Conversely, although APRIL mRNA
showed an increase in AIDþ synovial tissue, these differences
did not reach statistical signiﬁcance (Figure 2E).
AID Identifies Interfollicular Large B Cells within the
Rheumatoid Synovial Membrane in Association with FDC-
Positive Aggregates
In addition to AIDþB cells within FDCþnetworks, a second
set of cells within the synovial membrane expressed AID
outside this compartment. These cells were characterised by a
large cytoplasm, often with a dendritic morphology, and were
localized in close association with neighbouring T cells
exclusively in CD21þ aggregates (Figure 3A and 3B). Using
double immunoﬂuorescence for AID and CD20 (Figure 3C
and 3D), we conﬁrmed that these AIDþ cells were of B cell
origin. The morphological appearance, tissue distribution,
and predominant cytoplasmic AID expression in these cells
(Figure 3E and 3F) closely resembles the population of IF
large B cells recently described in lymph nodes [22] where
AIDþ IF large B cells are mainly localised within the T cell
area surrounding the follicles [21,23].
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Figure 3. AID Expression within the Rheumatoid Synovial Membrane Identifies Interfollicular Large B Cells
(A) Paraffin-embedded sections from RA patients were stained for AID (203magnification). AIDþ cells with a large cytoplasm and sometimes dendritic-
like morphology (arrows) were frequently and exclusively seen in RA synovial tissue characterized by the presence of large aggregates predominantly in
close proximity to CD21þ FDC networks.
(B) Paraffin sections were double stained for AID (brown) and CD3 (red) (603magnification), demonstrating the close relationship between AID positive
cells (arrows) and T cells in the peripheral T cell areas of the lymphoid aggregates.
(C) Merged double staining for AID (red) and CD20 (green) on frozen RA sections confirmed that AIDþ cells were of B cell origin (double-stained cells are
identified in yellow).
(D) Higher magnification of an example of an AIDþ/CD20þ cell (603magnification of [C]).
(E and F) Scattered AIDþ cells (E) with the appearance of IF B cells (F) were occasionally found away from the central focus of the aggregate. Scale bars:
200 lm (A, C, E), 50 lm (B, F), 15 lm (D).
doi:10.1371/journal.pmed.0060001.g003
Figure 2. AID mRNA within Rheumatoid Synovial Tissue Is Expressed Exclusively in Association with CD21L-Isoform Transcripts
QT-PCR was used to measure levels of transcripts of AID and CD21L in synovial samples from 25 patients with RA. Results were normalized for the
endogenous control (human b-actin) and expressed as relative quantification.
(A) The presence of AID is restricted to those tissues expressing CD21L.
(B) Representative examples of the PCR products were run in a 1.8% agarose gel to ensure the presence of a single specific amplification product and
confirm specficity of QT-PCR. Amplicons of the expected length (99 bp for AID and CD21L and 171 bp for b-actin) were observed in samples that gave
positive signals at QT-PCR (lane 2), while no bands were detected in samples negative for AID/CD21L by QT-PCR (lane 3). No AID/CD21L amplification
was detectable in negative controls (CD3-sorted cells, lane 4), while AID and CD21L were both detectable in control human lymph node (lane 5).
(C–F) CXCL13, LTb, BAFF, and APRIL transcript analysis by QT-PCR. AID expression within synovial tissue was associated with the up-regulation of both
CXCL13 and LTb but no significant difference was seen in the levels of APRIL and BAFF. The lower and upper margins of the box represent the 25th and
75th percentiles, with the extended arms representing the 10th and 90th percentiles, respectively. The median is shown as a horizontal line within the
box. p-Values were calculated using the Mann-Whitney U test.
doi:10.1371/journal.pmed.0060001.g002
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Figure 4. AIDþ Aggregates Are Surrounded by Plasma Cells Producing ACPA within Rheumatoid Synovium
(A) Immunoblot analysis of reactivity of pooled ACPAþ and RA sera to citrullinated fibrinogen (CFb) (lanes 2 and 4) and control non-citrullinated
fibrinogen (Fb) (lanes 1 and 3). Two protein bands between 60–80 kDa in size, corresponding to the a- and b-chains of CFb, are recognized by the
ACPAþ RA sera (lane 2) but not control Fb (lanes 1). ACPA sera (lanes 3 and 4) show no immunoreactivity toward either citrullinated or control Fb.
(B–I) Double or single immunofluorescence analysis showing phenotypic characterization and immunoreactivity towards citrullinated proteins within
RA synovial tissue. Sequential sections of RA synovial tissue were double stained with anti-CD20 to detect B-cells (green) together with either
biotinylated CFb (B, red) or control biotinylated Fb (C). Sections were counterstained with DAPI. Positive staining is only seen in the sections incubated
with biotinylated CFb, confirming the presence of anti-citrullinated protein immunoreactivity.
(D–I) Sequential sections of rheumatoid synovium stained with anti-CD21 to detect FDC (D), anti-AID (E), double stained with anti-CD20 (green) and
biotinylated CFb (red) (F, G) and double stained with anti-CD138 (green) to detect plasma cells and biotinylated CFb (red) (H, I). CD21 was visualized
with vector red. AID, CD20, CD138, and biotinylated CFb were incubated with secondary Abs/streptavidin conjugated to ALEXA fluorochromes. AID and
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AID-Positive Follicles Are Surrounded by Plasma Cells
Producing ACPA
We next investigated whether AIDþ/FDCþ GC-like struc-
tures within the rheumatoid synovial membrane were
associated with the in situ production of ACPA.
Biotinylated citrullinated ﬁbrinogen (CFb) was produced as
previously reported [43] and tested for speciﬁcity using
pooled sera from three ACPAþ and three ACPA patients
with RA. As expected, ACPAþ sera showed reactivity to CFb
but not to unmodiﬁed Fb (Figure 4A, lanes 1 and 2), whilst no
reactivity was observed with ACPA sera (Figure 4A, lanes 3
and 4). Biotinylated CFb and biotinylated Fb were then used
to detect in situ production of ACPA in sections double
stained for CD20 (Figure 4B and 4C). Numerous positive cells
were detected with CFb (Figure 4B) but not when using Fb as
a negative control (Figure 4C) in ACPAþ patients. Conversely
no staining was seen around germinal centres from a sample
from an ACPA patient (data not shown).
ACPAþ cells were localised around AIDþ/CD21þ aggregates
(Figure 4D, 4E and 4F), were CD20 (Figure 4F and 4G) and
CD138þ (Figure 4H and 4I), conﬁrming their plasma cell
origin. These results suggest that AIDþ GC-like structures
within rheumatoid synovial tissue can support the local
differentiation of ACPA-producing plasma cells.
AID Expression Is Maintained within RA Synovial Grafts in
the HuRA-SCID Mouse Chimera Model, Sustains Ongoing
CSR and Supports the Production of ACPA
The histomorphological analysis described above suggested
that ectopic AIDþ/CD21þaggregates are capable of sustaining
in situ ACPA production in the RA synovium. We next
examined a) the direct functional relationship between the
synovial expression of AID and CD21L and the production of
ACPA and b) whether ectopic lymphoid aggregates within RA
synovium maintain functionality independently from incom-
ing immune cells from the periphery. To this end, we
generated Hu-RA SCID mice chimeras by implanting frag-
ments of RA synovial tissue into these animals (Figure 5A and
5B), and analysed the results at 4 wk.
(i) AID/CD21L expression and B cell proliferation are
maintained within RA synovial grafts. Histomorphology and
immunohistological analysis of parafﬁn-embedded sections
of transplanted RA synovium demonstrated viable grafts with
residual inﬂammatory inﬁltrates (Figure 5C), often charac-
terized by persistent FDC networks and associated AID
expression (Figure 5D and 5E). Importantly, AID was detected
only in the presence of CD21L in synovial grafts and AID
mRNA expression levels closely correlated (r¼0.88) with those
of CD21L (Figure 5G). In addition to the expression of AID,
further evidence of functional activation of B cells within
synovial grafts was determined by performing double staining
for the B cell marker CD20 and Ki67, a marker of cell
proliferation. Double stained, proliferating B cells were
identiﬁed within aggregates within grafts at 2 wk (Figure
5F), conﬁrming that B cells within synovial grafts are able to
both survive and proliferate in this micro environment, and
hence, retain the capacity to function as GC B cells.
(ii) AID and CD21L expression in RA synovial grafts is
associated with the up-regulation of genes regulating ectopic
lymphoneogenesis. To evaluate whether the sustained ex-
pression of AID and CD21L mRNA in RA synovial grafts was
associated with dynamic gene expression regulating ectopic
lymphoneogenesis, we analysed mRNA expression levels of
CXCL13, LTb, TNFa, APRIL, and BAFF. As shown in Figure
5H-5K, expression levels of the TNF family members LTb,
TNFa, and APRIL, as well as the lymphoid chemokine
CXCL13 were signiﬁcantly higher in AIDþ RA grafts as
compared to AID grafts. Conversely, although BAFF was
abundantly expressed in all RA synovial grafts, no signiﬁcant
differences between AIDþ and AID grafts were found. These
results are in keeping with previous reports [49], showing no
difference in the expression patterns of BAFF between
CD21þ and CD21 synovial tissues, but an up-regulation of
APRIL mRNA in GCþ synovitis, and indicate that ectopic
lymphoneogenesis in RA synovium develops and is main-
tained in the presence of high expression levels of these
factors.
(iii) AID and CD21L expression in RA synovial grafts is
associated with ongoing CSR and in situ production of ACPA
antibodies. In order to conﬁrm that AID expression in RA
synovial grafts was functional, evidence of ongoing CSR was
sought by analysing for the expression of circular transcripts.
Circular transcripts are known to be speciﬁcally associated
with AID expression and exclusively detectable in B cells
undergoing CSR, but not by plasma cells, which have already
undergone CSR [50]. By performing RT-PCR for Ic-Cl
circular transcripts, which are transiently produced for
around 48 h following class switching from IgM to IgG [50],
we demonstrated (Figure 6A) their invariable detection in
those RA transplants also expressing AID and CD21L mRNA,
conﬁrming the functionality of AID expression in synovial
grafts.
(iv) Levels of human ACPA in the mouse circulation are
associated with intra-graft expression of AID and CD21L
mRNA. Finally, we investigated whether there was a direct
relationship between AID and CD21L mRNA expression
within transplanted RA synovial grafts and the production of
class-switched human IgG ACPA detectable in the mouse
circulation. Strikingly, ACPA were only detected in the sera
of mice transplanted with RA synovial tissues expressing AID
and CD21L mRNA (Figure 6B). In addition, the highest levels
of ACPA in the serum were detected in the RA transplants
that were histologically characterized by an aggregate pattern
and high levels of AID mRNA expression (Figure 6B). The
levels of ACPA decreased in line with the decrease of AID
mRNA expression, whilst no ACPA were detected in AID
grafts with a diffuse pattern (Figure 6B). To establish the
relationship within the same patient between the variable
levels of AID expression and ACPA production, multiple
synovial grafts (n ¼ 20) obtained from the same joint of the
same patient with RA were stratiﬁed according to the
presence or absence of AID as determined by QT-PCR
(Figure 6D, P1). We demonstrated that circulating ACPA
from synovial grafts were produced at a signiﬁcantly higher
CD20 were counterstained with DAPI. ACPA Ab-producing cells were seen scattered around FDC and AIDþ aggregates (F). ACPAþ cells were
consistently CD20 (G) (603magnification of F) and CD138þ (H) (603magnification of G). Original magnification was 203 (B–F, H). Scale bars: 200 lm
(D–F, H), 50 lm (B, C) 20 lm (G, I).
doi:10.1371/journal.pmed.0060001.g004
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level in AIDþ grafts, while ACPA were negligible in the serum
of animals transplanted with AID grafts (Figure 6C). These
data indicate that, despite the known variability between
different synovial biopsies within the same patient, a func-
tional relationship between AID expression and ACPA
production is maintained.
Discussion
In this report we provide strong evidence that lymphoid
structures in the target organs of a human autoimmune
disease are functional by demonstrating that within the
synovial membrane of patients with RA, ectopic lymphoid
aggregates characterized by FDC networks invariably express
AID and are surrounded by ACPA producing plasma cells. In
addition, using the human RA-SCID mouse chimera model,
we demonstrate that transplanted RA synovial grafts con-
taining ectopic lymphoid structures support B cell survival
and proliferation, maintain AID expression, continuously
promote ongoing CSR and produce human IgG ACPA. This
phenomenon, characterized by the sustained high expression
levels of genes regulating ectopic lymphoneogenesis and in
the absence of new inﬂux of immune cells, indicates that the
establishment of follicular structures in the synovium can
lead to self-perpetuating autoimmunity. The self-sustained
survival of B cell niches, within rheumatoid synovium, may
also have a critical impact on the capacity of B cell–depleting
biologics to modulate chronic inﬂammation and autoim-
munity.
The elucidation of the mechanisms coupling chronic
inﬂammation and the production of disease speciﬁc autoanti-
bodies within RA synovium is of pivotal importance because
ACPA are highly disease speciﬁc markers of RA, are strongly
associated with a more destructive arthritis and are inde-
pendent predictors of a poorer prognosis [9,10]. However,
despite recent evidence that ACPA can mediate tissue
damage in animal models [12], conﬁrmation of a direct
pathogenic role for ACPA in patients with RA is currently
lacking. The presence of ectopic GC-like structures, charac-
terized by T/B cell aggregates and CD21þ FDC networks, in
the synovium of a subset of patients with RA has long been
known. These structures have been associated with the
expression of cellular and molecular markers associated with
GC responses in secondary lymphoid organs [26,27,51] and
analysis of Ig sequences from microdissected GCs from
synovial tissue has demonstrated hypermutated and clonally
related sequences [31], suggesting that an antigen driven B
cell response is ongoing within RA synovium. Nonetheless,
direct evidence that ectopic lymphoid tissue in RA synovium
contains the required molecular machinery to sustain on-
going CSR and afﬁnity maturation of autoantibodies has so
far been lacking. Recent evidence has demonstrated that the
processes of SHM and CSR are critically dependent on the
expression of the enzyme AID [17] and that AID expression is
exclusively associated with B cells undergoing SHM and CSR
[52]. Therefore delineating its expression pattern has allowed
us to establish that B cells activate the molecular machinery
responsible for production of afﬁnity matured antibodies in
follicular structures within the RA synovial membrane.
In this study we provide, to our knowledge, the ﬁrst
demonstration that AID is invariably expressed within
rheumatoid synovial T/B cell aggregates containing CD21þ
FDC networks, with a distribution closely recapitulating that
seen in secondary lymphoid organs, providing direct evi-
dence that ectopic GC-like structures represent a functional
tertiary lymphoid organ capable of activating the molecular
machinery necessary to sustain SHM and CSR within the
synovial membrane. Accordingly, ongoing CSR, as demon-
strated by the expression of circular transcripts, was
invariably detectable within AIDþ/FDCþ RA synovial tissues.
These results conﬁrm and expand our recent observations in
Sjo¨gren’s syndrome [42] in which FDCs appeared necessary
for sustaining AID expression in the ectopic lymphoid tissue
found in salivary glands, where an antigen-driven B cell
response can occur [53]. This evidence, further supported by
our data demonstrating the presence of AID transcripts only
in the presence of CD21L mRNA, strongly supports the
conclusion that within the rheumatoid synovial membrane,
AID requires the presence of FDCs for expression. We also
provide further histological evidence supporting both the
functionality of these AIDþ structures and their involvement
in the production of ACPA by showing that these structures
are surrounded by ACPA producing plasma cells.
In addition to the expression of AID by B cells within
ectopic GC-like structures, we also report the novel observa-
tion that the expression of AID within synovial tissue
identiﬁes a newly characterised subset of B cells, deﬁned as
IF large B cells [21]. These cells have been shown to express
AID outside of GCs in secondary lymphoid organs [21,23],
while the presence of somatic mutations within their Ig genes
[22] supports AID functionality. Importantly, among the RA
samples that we analysed, AIDþ IF large B cells were found
Figure 5. Rheumatoid Synovial Grafts in SCID Mice Maintain AID Expression and the Up-regulation of Genes Determining Lymphoneogenesis
(A) Rheumatoid synovial tissue (n ¼ 56) was transplanted into SCID mice (arrows depict site of transplants).
(B) Transplanted RA synovial tissue in SCID mouse.
(C–F) Montage image of a paraffin embedded haematoxylin and eosin stained section of transplanted tissue depicting the whole graft (original
magnification 43, area outlined in black equates to aggregate seen at higher magnification in [D] and [E]). Sequential sections of transplants stained
using conventional immunohistochemistry for CD21 (D), AID (E), and double immunofluorescence for Ki67 (green) and CD20 (red) (F) (inset at 403
magnification, with arrowheads indicating the cells staining positively for Ki67 and CD20) demonstrated persistent FDCs, associated expression of AID
(original magnification 403) and continued proliferation of B cells. Four weeks post-transplantation, total RNA from the grafts was reverse transcribed
and used for QT-PCR to determine the mRNA expression levels of AID and CD21L and a number of genes known to correlate with lymphoid tissue
organization.
(G) A significant correlation between levels of transcripts for AID and CD21L was found and AID was detected only in the presence of CD21L.
(H–L) Tissues were stratified according to the presence or absence of AID as determined by QT-PCR, and analysed for the expression of the selected
cytokines/chemokines genes between the groups. A significant difference is seen in levels of APRIL (H), CXCL13 (L), TNFa (J), and LTb (K). Significant p-
values are depicted, Mann-Whitney U test. No significant difference is seen between levels of BAFF (I). The lower and upper margins of the box
represent the 25th and 75th percentiles, with the extended arms representing the 10th and 90th percentiles, respectively. The median is shown as a
horizontal line within the box. Scale bars: 6 mm (B) 2 mm (C), 50 lm (D, E, F).
doi:10.1371/journal.pmed.0060001.g005
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exclusively in synovial aggregates containing ectopic GCs,
raising the possibility that they may represent a population of
post-GC B cells. In addition, they share many similarities with
IF large B cells in secondary lymphoid organs, namely their
localisation within the peripheral T cell area, a predom-
inantly cytoplasmic AID staining pattern and a dendritic
morphology [22]. We have recently reported their presence in
ectopic GC-like structures in salivary glands of patients with
Sjo¨gren’s syndrome [42], suggesting that these cells are
associated with sites of ectopic lymphoneogenesis in the
target organs of several autoimmune disorders. The role of IF
large B cells is currently unknown, but their dendritic-like
morphology and close association with T cells has led to
speculation that they may play an important role as antigen
presenting cells [22].
By evaluating the expression of CD21L and AID mRNA
using QT-PCR, a sensitive and highly speciﬁc method, we
were able to identify functional sites of ectopic lymphoneo-
genesis in about 50% of the RA synovial samples. This
prevalence was signiﬁcantly higher than that observed using
histological analysis and semiquantitative PCR reported in
approximately 25% [26], and is in line with a recent
observation by other groups [54]. These additional (low)
CD21Lþ tissues were always of aggregate appearance, and
were invariably accompanied by AID expression and ongoing
CSR, strongly supporting the concept that such aggregate
structures are also functional. These results demonstrate that
the presence of lymphoid aggregates and ongoing GC
reactions in RA synovium is a phenomenon considerably
more common than has recently been proposed [30,37,38].
In this report, by using the HuRA-SCID mouse model we
were able to provide direct evidence of functionality and to
present a number of novel ﬁndings regarding the production
of ACPA within the rheumatoid synovial membrane. First, as
in the original RA synovial tissue, the expression of AID
within the transplanted tissue was consistently associated
with the presence and levels of CD21L. This, in turn, was
invariably associated with ongoing CSR and the production
of human IgG ACPA detectable in the mouse sera. In
addition, levels of AID within the RA transplants directly
correlated with the levels of ACPA in the mouse sera. Finally,
even low-level expression of AID and CD21L within the
transplants was still associated with signiﬁcant ACPA detec-
tion in the sera, while ACPA were barely detectable in the
absence of AID mRNA expression in the RA grafts. Overall,
these results strongly support the notion that lymphoid
structures expressing AID and CD21L can directly contribute
to ACPA production within the rheumatoid synovial mem-
brane. Indeed, as further evidence of AID functionality within
synovial tissue, we demonstrated that AID expression
supports the expression of Ic-Cl circular transcripts in the
RA synovial grafts, and hence the presence of ongoing class-
switching from IgM to IgG. Because circular transcripts are
only transiently produced in association with CSR [50], this
demonstrates that class-switching is still ongoing within the
RA synovial grafts, a result in line with the detection of
human IgG ACPA in the mouse circulation. It is important to
emphasise that these experiments cannot formally exclude
the possibility that pre-existing long-lived plasma cells, either
generated in situ or migrated from secondary lymphoid
organs, might also contribute to the production of ACPA in
RA synovium and in transplanted animals. Despite this
limitation, the topographical proximity of ACPA-producing
plasma cells to AIDþ follicular structures and the close
association between the level of ACPA production in the
mouse serum and higher levels of AID within the same tissue
strongly suggest that autoreactive plasma cells can be
generated within ectopic lymphoid tissue. This concept is in
agreement with the signiﬁcantly higher levels of synovial
ACPA recently demonstrated in synovial tissues containing
lymphoid aggregates [55]. The lack of detection of GC CD20þ
B cells reacting with citrullinated ﬁbrinogen is in line with
previous reports showing that reactivity toward labelled
autoantigens is typically restricted to plasma cells surround-
ing ectopic GCs [43,56], and is in all probability due to the low
density of antigen-speciﬁc antibodies on the cell surface of
CD20þB cells compared to the much higher quantity of high-
afﬁnity antibodies produced by plasma cells as they migrate
out of GC. Finally, although the evidence that we provide is
highly suggestive of a direct role for AIDþ lymphoid
structures in generating in situ autoantibody-producing cells,
a formal demonstration would require evidence, i.e., in the
SCID-HuRA model, that disruption of FDC networks abro-
gates plasma cell differentiation and ACPA production.
A ﬁnal and highly relevant observation obtained in the
HuRA-SCID chimera is that the RA synovium, in the presence
of follicular structures expressing AID and CD21L, behaves as
a self-sustained microanatomical unit of ectopic lymphoid
tissue. Furthermore, within the time frame analysed, the RA
synovium supports the proliferation of B cells and maintains
an intrinsic ability to function as an autoantibody-producing
site independent of circulating immune cells. The continued
Figure 6. ACPA Production in the HuRA-SCID Mouse Is Associated with Functional AID Expression within Synovial Grafts
Specimens of synovium from six patients with RA were transplanted into 34 SCID mice. Four weeks post-transplantation mice were killed and all sera
tested for the presence of ACPA, while mRNA from the grafts (n ¼ 56) was reverse transcribed and used for QT-PCR to determine the number of
transcripts for AID and CD21L, as well as for RT-PCR to determine the presence of circular transcripts.
(A) A 1.8% agarose gel showing representative PCR products from RT-PCR performed for Ic-Cl circular transcripts (double bands representing
alternatively spliced transcripts and confirming specificity [47]) indicating ongoing CSR in synovial grafts positive for AID/CD21L and producing ACPA
(lane 3 and 4) but not in transplants negative for AID/CD21L (lane 2).
(B) Synovial transplants from six RA patients were grouped according to histological classification, as aggregate versus diffuse, and activation-induced
cytidine deaminase, CD21L mRNA expression as high (þþ), low (þ), and negative (). Significantly higher levels of anti-citrullinated protein/peptide
antibodies were seen in those mice transplanted with synovium expressing high mRNA levels of AID/CD21L. Notably, ACPA were not seen in the
absence of AID.
(C and D) To establish the relationship within the same patient between levels of AID expression and ACPA production, synovial grafts from an
illustrative patient (P1) were stratified according to the presence or absence of AID as determined by QT-PCR (D) (horizontal line indicates cut off for
positivity). Circulating ACPA from synovial grafts were produced at a significantly higher level in AIDþcompared to AIDgrafts. Error bars indicate mean
levels of ACPAþ SD. p-Values were calculated using Kruskal-Wallis test (B) and Mann Whitney U test (C).
doi:10.1371/journal.pmed.0060001.g006
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expression of AID and CD21L and the association with
ongoing CSR and ACPA production in this environment
support a key role for ectopic lymphoid tissue within the
synovial membrane in driving the ongoing disease process,
and may also explain the lack of direct correlation between
peripheral B cell depletion and clinical response to the anti-
CD20 monoclonal antibody rituximab [57,58]. The persis-
tence of ectopic lymphoid structures in RA synovial tissues
following transplantation into SCID mice is likely to be
related to the sustained overexpression of genes regulating
ectopic lymphoneogenesis and autoreactive B cell survival,
such as the TNF family members LTb, TNFa, and APRIL, as
well as the lymphoid chemokine CXCL13 [26,27]. LTb, TNFa,
and CXCL13 were all signiﬁcantly more highly expressed in
AIDþ/CD21Lþ as compared to AID/CD21L RA tissues, and
high expression was maintained in RA synovial grafts
displaying AID, ongoing CSR, and ACPA production. We
suggest that the up-regulation of these key cytokines within
RA synovial tissue allows differentiation and maintenance of
FDC networks within T/B cell aggregates to form functional
microanatomical immunological units, and hence, allow the
up-regulation of AID and subsequent production of ACPA. In
addition, our results might also explain the fall in ACPA levels
resulting from the dual blockade of TNFa and LTa with
etanercept [59], and the blockade of TNFa by inﬂiximab [11]
in patients with RA.
In conclusion, our work demonstrates that ectopic GC-like
structures are not only functional in rheumatoid synovitis,
but that their presence may contribute to disease patho-
genesis via the production of ACPA. These data elucidate the
mechanism of production of ACPA in the synovial membrane
and thereby provide evidence of a pivotal role for AID in the
pathogenesis of RA. We therefore propose that AID may be
targeted for the development of novel therapeutic agents.
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Editors’ Summary
Background. More than 1 million people in the United States have
rheumatoid arthritis, an ‘‘autoimmune’’ condition that affects the joints.
Normally, the immune system provides protection against infection by
responding to foreign antigens (molecules that are unique to invading
organisms) while ignoring self-antigens present in the body’s own
tissues. In autoimmune diseases, this ability to discriminate between self
and non-self fails for unknown reasons and the immune system begins
to attack human tissues. In rheumatoid arthritis, the lining of the joints
(the synovium) is attacked, it becomes inflamed and thickened, and
chemicals are released that damage all the tissues in the joint. Eventually,
the joint may become so scarred that movement is no longer possible.
Rheumatoid arthritis usually starts in the small joints in the hands and
feet, but larger joints and other tissues (including the heart and blood
vessels) can be affected. Its symptoms, which tend to fluctuate, include
early morning joint pain, swelling, and stiffness, and feeling generally
unwell. Although the disease is not always easy to diagnose, the immune
systems of many people with rheumatoid arthritis make ‘‘anti-
citrullinated protein/peptide antibodies’’ (ACPA). These ‘‘autoantibod-
ies’’ (which some experts believe can contribute to the joint damage in
rheumatoid arthritis) recognize self-proteins that contain the unusual
amino acid citrulline, and their detection on blood tests can help make
the diagnosis. Although there is no cure for rheumatoid arthritis, the
recently developed biologic drugs, often used together with the more
traditional disease-modifying therapies, are able to halt its progression
by specifically blocking the chemicals that cause joint damage. Painkillers
and nonsteroidal anti-inflammatory drugs can reduce its symptoms, and
badly damaged joints can sometimes be surgically replaced.
Why Was This Study Done? Before scientists can develop a cure for
rheumatoid arthritis, they need to know how and why autoantibodies
are made that attack the joints in this common and disabling disease. B
cells, the immune system cells that make antibodies, mature in structures
known as ‘‘germinal centers’’ in the spleen and lymph nodes. In the
germinal centers, immature B cells are exposed to antigens and undergo
two genetic processes called ‘‘somatic hypermutation’’ and ‘‘class-switch
recombination’’ that ensure that each B cell makes an antibody that
sticks as tightly as possible to just one antigen. The B cells then multiply
and enter the bloodstream where they help to deal with infections.
Interestingly, the inflamed synovium of many patients with rheumatoid
arthritis contains structures that resemble germinal centers. Could these
ectopic (misplaced) lymphoid structures, which are characterized by
networks of immune system cells called follicular dendritic cells (FDCs),
promote autoimmunity and long-term inflammation by driving the
production of autoantibodies within the joint itself? In this study, the
researchers investigate this possibility.
What Did the Researchers Do and Find? The researchers collected
synovial tissue from 55 patients with rheumatoid arthritis and used two
approaches, called immunohistochemistry and real-time PCR, to inves-
tigate whether FDC-containing structures in synovium expressed an
enzyme called activation-induced cytidine deaminase (AID), which is
needed for both somatic hypermutation and class-switch recombination.
All the FDC-containing structures that the researchers found in their
samples expressed AID. Furthermore, these AID-containing structures
were surrounded by mature B cells making ACPAs. To test whether these
B cells were derived from AID-expressing cells resident in the synovium
rather than ACPA-expressing immune system cells coming into the
synovium from elsewhere in the body, the researchers transplanted
synovium from patients with rheumatoid arthritis under the skin of a
special sort of mouse that largely lacks its own immune system. Four
weeks later, the researchers found that the transplanted human
lymphoid tissue was still making AID, that the level of AID expression
correlated with the amount of human ACPA in the blood of the mice,
and that the B cells in the transplant were proliferating.
What Do These Findings Mean? These findings show that the ectopic
lymphoid structures present in the synovium of some patients with
rheumatoid arthritis are functional and are able to make ACPA. Because
ACPA may be responsible for joint damage, the survival of these
structures could, therefore, be involved in the development and
progression of rheumatoid arthritis. More experiments are needed to
confirm this idea, but these findings may explain why drugs that
effectively clear B cells from the bloodstream do not always produce a
marked clinical improvement in rheumatoid arthritis. Finally, they
suggest that AID might provide a new target for the development of
drugs to treat rheumatoid arthritis.
Additional Information. Please access these Web sites via the online
version of this summary at http://dx.doi.org/10.1371/journal.pmed.
0060001.
 This study is further discussed in a PLoS Medicine Perspective by Rene
Toes and Tom Huizinga
 The MedlinePlus Encyclopedia has a page on rheumatoid arthritis (in
English and Spanish). MedlinePlus provides links to other information
on rheumatoid arthritis (in English and Spanish)
 The UK National Health Service Choices information service has
detailed information on rheumatoid arthritis
 The US National Institute of Arthritis and Musculoskeletal and Skin
Diseases provides Fast Facts, an easy to read publication for the public,
and a more detailed Handbook on rheumatoid arthritis
 The US Centers for Disease Control and Prevention has an overview on
rheumatoid arthritis that includes statistics about this disease and its
impact on daily life
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